Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer

被引：0
|
作者：
Malolan S Rajagopalan
Dwight E Heron
Rodney E Wegner
Herbert J Zeh
Nathan Bahary
Alyssa M Krasinskas
Barry Lembersky
Randall Brand
A James Moser
Annette E Quinn
Steven A Burton
机构：
[1] University of Pittsburgh Cancer Institute,Department of Radiation Oncology
[2] University of Pittsburgh Cancer Institute,Department of Surgical Oncology
[3] University of Pittsburgh Cancer Institute,Department of Medical Oncology
[4] University of Pittsburgh Medical Center,Department of Pathology
[5] University of Pittsburgh Medical Center,Department of Gastroenterology
[6] Beth Israel Deaconess Medical Center,Department of Surgery
[7] Delta Medix Center for Comprehensive Cancer Care,undefined
来源：
Radiation Oncology | / 8卷
关键词：
Pancreatic cancer; Stereotactic body radiotherapy; SBRT; Neoadjuvant; Pathologic response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer
    Rajagopalan, Malolan S.
    Heron, Dwight E.
    Wegner, Rodney E.
    Zeh, Herbert J.
    Bahary, Nathan
    Krasinskas, Alyssa M.
    Lembersky, Barry
    Brand, Randall
    Moser, A. James
    Quinn, Annette E.
    Burton, Steven A.
    [J]. RADIATION ONCOLOGY, 2013, 8
  • [2] Pathologic Response With Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
    Rajagopalan, M. S.
    Heron, D. E.
    Zeh, H. J.
    Moser, A. J.
    Krasinskas, A. M.
    Quinn, A. E.
    Burton, S. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S319 - S320
  • [3] Neoadjuvant chemotherapy and radiotherapy outcomes in borderline-resectable and locally-advanced pancreatic cancer patients
    Botta, Gregory P.
    Huynh, Tridu R.
    Spierling-Bagsic, Samantha R.
    Agelidis, Alexander
    Schaffer, Randolph
    Lin, Ray
    Sigal, Darren
    [J]. CANCER MEDICINE, 2023, 12 (07): : 7713 - 7723
  • [4] Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy
    Mellon, Eric A.
    Jin, William H.
    Frakes, Jessica M.
    Centeno, Barbara A.
    Strom, Tobin J.
    Springett, Gregory M.
    Malafa, Mokenge P.
    Shridhar, Ravi
    Hodul, Pamela J.
    Hoffe, Sarah E.
    [J]. ACTA ONCOLOGICA, 2017, 56 (03) : 391 - 397
  • [5] Pathologic Outcomes in Borderline Resectable and Locally Advanced Pancreatic Cancer Patients Receiving Neoadjuvant Stereotactic Body Radiation Therapy
    Rosati, L. M.
    He, J.
    Moningi, S.
    Hacker-Prietz, A.
    Huebner, T. A.
    Assadi, R. K.
    Laheru, D. A.
    Zheng, L.
    De Jesus-Acosta, A.
    Le, D. T.
    Fishman, E. K.
    Hruban, R. H.
    Hirose, K.
    Makary, M. A.
    Cameron, J. L.
    Pawlik, T. M.
    Wolfgang, C. L.
    Weiss, M. J.
    Ellsworth, S. G.
    Herman, J. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E127 - E128
  • [6] Predictors and Survival for Pathologic Tumor Response Grade in Borderline Resectable and Locally Advanced Pancreatic Cancer Treated With Induction Chemotherapy and Neoadjuvant Stereotactic Body Radiation Therapy
    Mellon, E. A.
    Hoffe, S. E.
    Frakes, J. M.
    Strom, T.
    Springett, G. M.
    Shridhar, R.
    Centeno, B. A.
    Malafa, M. P.
    Chuong, M. D.
    Hodul, P. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E165 - E165
  • [7] Predictors and survival for pathologic tumor response grade (TRG) in borderline resectable (BRPC) and locally advanced pancreatic cancer (LAPC) treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy (SBRT).
    Mellon, Eric Albert
    Hoffe, Sarah E.
    Frakes, Jessica M.
    Strom, Tobin Joel Crill
    Springett, Gregory M.
    Shridhar, Ravi
    Centeno, Barbara
    Malafa, Mokenge Peter
    Hodul, Pamela Joy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [8] Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
    Reddy, Abhinav, V
    Hill, Colin S.
    Sehgal, Shuchi
    Ding, Ding
    Hacker-Prietz, Amy
    He, Jin
    Zheng, Lei
    Herman, Joseph M.
    Meyer, Jeffrey
    Narang, Amol K.
    [J]. RADIATION ONCOLOGY JOURNAL, 2021, 39 (04): : 304 - 314
  • [9] Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
    Mellon, Eric A.
    Hoffe, Sarah E.
    Springett, Gregory M.
    Frakes, Jessica M.
    Strom, Tobin J.
    Hodul, Pamela J.
    Malafa, Mokenge P.
    Chuong, Michael D.
    Shridhar, Ravi
    [J]. ACTA ONCOLOGICA, 2015, 54 (07) : 979 - 985
  • [10] Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
    Roberto Alva-Ruiz
    Lavanya Yohanathan
    Jennifer A. Yonkus
    Amro M. Abdelrahman
    Lindsey A. Gregory
    Thorvadur R. Halfdanarson
    Amit Mahipal
    Robert R. McWilliams
    Wen Wee Ma
    Christopher L. Hallemeier
    Rondell P. Graham
    Travis E. Grotz
    Rory L. Smoot
    Sean P. Cleary
    David M. Nagorney
    Michael L. Kendrick
    Mark J. Truty
    [J]. Annals of Surgical Oncology, 2022, 29 : 1579 - 1591
12345